Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices
2
CMS Announces GENEROUS Model to Lower Medicaid Drug Prices
3
Adolescents, Young Adults Use AI Chatbots for Mental Health Advice
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
